Thomas Waite | Deputy Chief Medical Officer
UK Department of Health

Thomas Waite, Deputy Chief Medical Officer, UK Department of Health

Dr Thomas Waite is the Deputy Chief Medical Officer leading on health protection. His role covers emergency response and preparedness, infectious diseases, vaccines and therapeutics. Dr Waite is a consultant epidemiologist and completed his clinical and public health training in south Wales. He is a graduate of the European Programme for Interventional Epidemiology Training and has postgraduate qualifications in public health, medical toxicology and medical education. Dr Waite has a wide range of experience dealing with outbreaks and environment emergencies in the UK, Africa, South East Asia and the Caribbean. Career highlights:

  • helped establish the UK Public Health Rapid Support Team. As the senior epidemiologist he led their first deployment to the Somali region of Ethiopia to respond to outbreaks of acute watery diarrhoea
  • in 2017 he was deployed to support health protection work in the Caribbean region as part of the recovery from hurricanes Irma and Maria
  • has held a range of leadership roles in Public Health England including the Extreme Event Health Protection team, NIS Global Public Health team and as Director of the Field Epidemiology Training Programme
  • during the COVID-19 pandemic, Dr Waite helped create the Joint Biosecurity Centre (JBC) and subsequently became its Director of Health Analysis
He was Interim Deputy Chief Medical Officer from July 2021 to April 2022 supporting the Chief Medical Officer on the COVID-19 response.

Appearances:



Day 1 - Tuesday 29th October @ 17:00

Can uptake keep up with the speed of vaccine developments?

-      Closing the uptake gap between child and adult immunisation

-      Current uptake issues: why is measles coming back and what can we do?

-      The importance of RWE, data & management in immunisation programmes

-      With 100+ vaccines in the pipeline; what are the realities for uptake and implementation?

-      Case studies from countries with high uptake of seasonal vaccines

last published: 10/Jun/24 12:45 GMT

back to speakers